1.	Phase III Study of Peripheral Blood Stem Cell Mobilization With Cyclophosphamide, Etoposide, and Either SC-70935 or Filgrastim (G-CSF) in Patients With Lymphoma (Summary Last Modified 02/2000) Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SC-IN5-98-02-007, CWRU-SEAR-1498
2.	Phase III Randomized Study of SC-70935 Following Docetaxel, Doxorubicin, and Cyclophosphamide in Patients with Recurrent or Newly Diagnosed Breast Cancer (Summary Last Modified 01/2000) Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SC-NN5-98-02-010
3.	Phase II Randomized Study of Leridistim vs Filgrastim (G-CSF) in Older Patients With Acute Myeloid Leukemia Receiving Cytarabine and Daunorubicin Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 55 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-99055, MCC-11506, SC-IN5-99-12-011, NCI-G99-1652, NCT00004215